Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice.

Alexandraki KI, Pizanias M, Uri I, Thomas D, Page T, Kolomodi D, Low CS, Adesanya O, Tsoli M, Gross DJ, Randeva H, Srirajaskanthan R, Grozinsky-Glasberg S, Kaltsas G, Weickert MO.

Endocrine. 2019 Jan 11. doi: 10.1007/s12020-019-01838-8. [Epub ahead of print]

PMID:
30635793
2.

The role of palbociclib in thyroid carcinoma with BRAF mutation.

Tsoukalas N, Tsapakidis K, Alexandraki KI.

Gland Surg. 2018 Aug;7(Suppl 1):S82-S85. doi: 10.21037/gs.2018.03.07. No abstract available.

3.

Gastric Carcinoids.

Grozinsky-Glasberg S, Alexandraki KI, Angelousi A, Chatzellis E, Sougioultzis S, Kaltsas G.

Endocrinol Metab Clin North Am. 2018 Sep;47(3):645-660. doi: 10.1016/j.ecl.2018.04.013. Epub 2018 Jul 11. Review.

PMID:
30098721
4.

Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasms.

Kyriakopoulos G, Mavroeidi V, Chatzellis E, Kaltsas GA, Alexandraki KI.

Ann Transl Med. 2018 Jun;6(12):252. doi: 10.21037/atm.2018.06.27. Review.

5.

Leptin Involvement in Primary Brain and Pituitary Tumors: Therapeutic Potential, Prognostic Value, and Proposed Diagnostic Application.

Bikis C, Tzanavari T, Alexandraki KI, Theocharis S.

Horm Cancer. 2018 Jun;9(3):144-155. doi: 10.1007/s12672-018-0327-8. Epub 2018 Feb 20. Review.

PMID:
29464548
6.

Acetyl Cholinesterase Inhibitors and Cell-Derived Peripheral Inflammatory Cytokines in Early Stages of Alzheimer's Disease.

Kokras N, Stamouli E, Sotiropoulos I, Katirtzoglou EA, Siarkos KT, Dalagiorgou G, Alexandraki KI, Coulocheri S, Piperi C, Politis AM.

J Clin Psychopharmacol. 2018 Apr;38(2):138-143. doi: 10.1097/JCP.0000000000000840.

PMID:
29420357
7.

Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms.

Alexandraki KI, Karapanagioti A, Karoumpalis I, Boutzios G, Kaltsas GA.

Biomed Res Int. 2017;2017:9856140. doi: 10.1155/2017/9856140. Epub 2017 Nov 19. Review.

8.

IGF-IEc expression is increased in secondary compared to primary foci in neuroendocrine neoplasms.

Alexandraki KI, Philippou A, Boutzios G, Theohari I, Koutsilieris M, Delladetsima IK, Kaltsas GA.

Oncotarget. 2017 Sep 8;8(45):79003-79011. doi: 10.18632/oncotarget.20743. eCollection 2017 Oct 3.

9.

Association of skin autofluorescence with arterial properties: A closer look at AGE Reader and EndoPAT 2000 commercial devices.

Papaioannou TG, Alexandraki KI, Karamanou M, Piperi C, Tousoulis D.

Exp Gerontol. 2017 Nov;98:207-208. doi: 10.1016/j.exger.2017.08.035. Epub 2017 Sep 4. No abstract available.

PMID:
28882506
10.

Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literature.

Tsoukalas N, Chatzellis E, Rontogianni D, Alexandraki KI, Boutzios G, Angelousi A, Kaltsas G.

Medicine (Baltimore). 2017 Apr;96(16):e6201. doi: 10.1097/MD.0000000000006201. Review.

11.

Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up.

Papanastasiou L, Alexandraki KI, Androulakis II, Fountoulakis S, Kounadi T, Markou A, Tsiavos V, Samara C, Papaioannou TG, Piaditis G, Kaltsas G.

Clin Endocrinol (Oxf). 2017 Apr;86(4):488-498. doi: 10.1111/cen.13294. Epub 2017 Jan 25.

PMID:
27992961
12.

Therapeutic Strategies for the Treatment of Severe Cushing's Syndrome.

Alexandraki KI, Grossman AB.

Drugs. 2016 Mar;76(4):447-58. doi: 10.1007/s40265-016-0539-6. Review.

PMID:
26833215
13.

Current strategies for the treatment of severe Cushing's syndrome.

Alexandraki KI, Grossman AB.

Expert Rev Endocrinol Metab. 2016 Jan;11(1):65-79. doi: 10.1586/17446651.2016.1123615. Epub 2015 Dec 14.

PMID:
30063449
14.

Hypophysitis in IgG4-Related Disease Associated with p-ANCA Vasculitis.

Alexandraki KI, Kaltsatou M, Chatzellis E, Goules AV, Boutzios G, Kolomodi D, Kaltsas GA.

Am J Med. 2016 Jun;129(6):e25-7. doi: 10.1016/j.amjmed.2015.11.021. Epub 2015 Dec 17. No abstract available.

PMID:
26706382
15.

Appendiceal neuroendocrine neoplasms: diagnosis and management.

Alexandraki KI, Kaltsas GA, Grozinsky-Glasberg S, Chatzellis E, Grossman AB.

Endocr Relat Cancer. 2016 Jan;23(1):R27-41. doi: 10.1530/ERC-15-0310. Epub 2015 Oct 19. Review.

PMID:
26483424
16.

Association between chronic pelvic pain symptoms and the presence of endometriosis.

Apostolopoulos NV, Alexandraki KI, Gorry A, Coker A.

Arch Gynecol Obstet. 2016 Feb;293(2):439-45. doi: 10.1007/s00404-015-3855-2. Epub 2015 Sep 2.

PMID:
26329801
17.

Adrenal Insufficiency.

Alexandraki KI, Grossman A.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. No abstract available.
2018 Aug 20.

18.

Adrenal Suppression.

Alexandraki KI, Kaltsas GA, Chrousos GP.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. No abstract available.
2018 Oct 1.

19.

Florid Cushing’s Syndrome.

Alexandraki KI, Grossman A.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2018 Apr 19.

20.

Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores.

Diakatou E, Alexandraki KI, Tsolakis AV, Kontogeorgos G, Chatzellis E, Leonti A, Kaltsas GA.

Clin Endocrinol (Oxf). 2015 Sep;83(3):420-8. doi: 10.1111/cen.12775. Epub 2015 Apr 24.

PMID:
25808161
21.

Aggressive pituitary tumors.

Chatzellis E, Alexandraki KI, Androulakis II, Kaltsas G.

Neuroendocrinology. 2015;101(2):87-104. doi: 10.1159/000371806. Epub 2015 Jan 5. Review.

22.

Hyperandrogenism after menopause.

Markopoulos MC, Kassi E, Alexandraki KI, Mastorakos G, Kaltsas G.

Eur J Endocrinol. 2015 Feb;172(2):R79-91. doi: 10.1530/EJE-14-0468. Epub 2014 Sep 15. Review.

PMID:
25225480
23.

Predictive value of gastrin levels for the diagnosis of gastric enterochromaffin-like cell hyperplasia in patients with Hashimoto's thyroiditis.

Nicolaou A, Thomas D, Alexandraki KI, Sougioultzis S, Tsolakis AV, Kaltsas G.

Neuroendocrinology. 2014;99(2):118-22. doi: 10.1159/000362879. Epub 2014 Apr 24.

PMID:
24776735
24.

Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms.

Kaltsas G, Grozinsky-Glasberg S, Alexandraki KI, Thomas D, Tsolakis AV, Gross D, Grossman AB.

Clin Endocrinol (Oxf). 2014 Aug;81(2):157-68. doi: 10.1111/cen.12476. Epub 2014 May 26. Review.

PMID:
24750249
25.

Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion.

Androulakis II, Kaltsas GA, Kollias GE, Markou AC, Gouli AK, Thomas DA, Alexandraki KI, Papamichael CM, Hadjidakis DJ, Piaditis GP.

J Clin Endocrinol Metab. 2014 Aug;99(8):2754-62. doi: 10.1210/jc.2013-4064. Epub 2014 Apr 8.

PMID:
24712565
26.

Incidence of pituitary incidentalomas in patients with adrenal adenomas.

Chrisoulidou A, Alexandraki KI, Kita M, Tsolakidou K, Papanastasiou L, Samara C, Anastasiou A, Piaditis G, Kaltsas G.

Exp Clin Endocrinol Diabetes. 2014 Jan;122(1):15-9. doi: 10.1055/s-0033-1358761. Epub 2014 Jan 24.

PMID:
24464594
27.

Metastatic type 1 gastric carcinoid: a real threat or just a myth?

Grozinsky-Glasberg S, Thomas D, Strosberg JR, Pape UF, Felder S, Tsolakis AV, Alexandraki KI, Fraenkel M, Saiegh L, Reissman P, Kaltsas G, Gross DJ.

World J Gastroenterol. 2013 Dec 14;19(46):8687-95. doi: 10.3748/wjg.v19.i46.8687.

28.

Are patients with autoimmune thyroid disease and autoimmune gastritis at risk of gastric neuroendocrine neoplasms type 1?

Alexandraki KI, Nikolaou A, Thomas D, Syriou V, Korkolopoulou P, Sougioultzis S, Kaltsas G.

Clin Endocrinol (Oxf). 2014 May;80(5):685-90. doi: 10.1111/cen.12346. Epub 2013 Nov 9.

PMID:
24118101
29.

Endocrinopathies and other disorders inducing a polycystic ovary syndrome phenotype.

Alexandraki KI, Kaltsas GA.

Front Horm Res. 2013;40:142-57. doi: 10.1159/000341846. Epub 2012 Oct 18.

PMID:
24002411
30.

Effects of low-dose metformin and rosiglitazone on biochemical, clinical, metabolic and biophysical outcomes in polycystic ovary syndrome.

Mohiyiddeen L, Watson AJ, Apostolopoulos NV, Berry R, Alexandraki KI, Jude EB.

J Obstet Gynaecol. 2013 Feb;33(2):165-70. doi: 10.3109/01443615.2012.745839.

PMID:
23445141
31.

Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study.

Alexandraki KI, Kaltsas GA, Isidori AM, Storr HL, Afshar F, Sabin I, Akker SA, Chew SL, Drake WM, Monson JP, Besser GM, Grossman AB.

Eur J Endocrinol. 2013 Mar 20;168(4):639-48. doi: 10.1530/EJE-12-0921. Print 2013 Apr.

PMID:
23371975
32.

Current size criteria for the management of neuroendocrine tumors of the appendix: are they valid? Clinical experience and review of the literature.

Grozinsky-Glasberg S, Alexandraki KI, Barak D, Doviner V, Reissman P, Kaltsas GA, Gross DJ.

Neuroendocrinology. 2013;98(1):31-7. doi: 10.1159/000343801. Epub 2012 Nov 22. Review.

PMID:
23051855
33.

Oncogene-induced senescence in pituitary adenomas and carcinomas.

Alexandraki KI, Munayem Khan M, Chahal HS, Dalantaeva NS, Trivellin G, Berney DM, Caron P, Popovic V, Pfeifer M, Jordan S, Korbonits M, Grossman AB.

Hormones (Athens). 2012 Jul-Sep;11(3):297-307.

34.

Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.

Alexandraki KI, Kaltsas G.

Endocrine. 2012 Feb;41(1):40-52. doi: 10.1007/s12020-011-9562-2. Epub 2011 Nov 29. Review.

PMID:
22124940
35.

Is urinary free cortisol of value in the diagnosis of Cushing's syndrome?

Alexandraki KI, Grossman AB.

Curr Opin Endocrinol Diabetes Obes. 2011 Aug;18(4):259-63. doi: 10.1097/MED.0b013e3283487193. Review.

PMID:
21681089
36.

Specific electrocardiographic features associated with Cushing's disease.

Alexandraki KI, Kaltsas GA, Vouliotis AI, Papaioannou TG, Trisk L, Zilos A, Korbonits M, Besser GM, Anastasakis A, Grossman AB.

Clin Endocrinol (Oxf). 2011 May;74(5):558-64. doi: 10.1111/j.1365-2265.2011.03975.x.

PMID:
21470280
37.

Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing's disease.

Storr HL, Alexandraki KI, Martin L, Isidori AM, Kaltsas GA, Monson JP, Besser GM, Matson M, Evanson J, Afshar F, Sabin I, Savage MO, Grossman AB.

Eur J Endocrinol. 2011 May;164(5):667-74. doi: 10.1530/EJE-10-1120. Epub 2011 Feb 10.

PMID:
21310872
38.

Clinical value of right hemicolectomy for appendiceal carcinoids using pathologic criteria.

Alexandraki KI, Griniatsos J, Bramis KI, Ballian N, Dimitriou N, Giannakakis T, Tsigris C, Felekouras E, Kaltsas GA.

J Endocrinol Invest. 2011 Apr;34(4):255-9. doi: 10.1007/BF03347081. Epub 2010 Oct 8.

PMID:
20935447
39.

Novel insights in the diagnosis of Cushing's syndrome.

Alexandraki KI, Grossman AB.

Neuroendocrinology. 2010;92 Suppl 1:35-43. doi: 10.1159/000314295. Epub 2010 Sep 10. Review.

40.

Medical therapy of Cushing's disease: where are we now?

Alexandraki KI, Grossman AB.

Front Horm Res. 2010;38:165-73. doi: 10.1159/000318507. Epub 2010 Jul 5. Review.

PMID:
20616508
41.

The ectopic ACTH syndrome.

Alexandraki KI, Grossman AB.

Rev Endocr Metab Disord. 2010 Jun;11(2):117-26. doi: 10.1007/s11154-010-9139-z. Review.

PMID:
20544290
42.

Light sensitivity and pain sensation during cataract surgery. A comparative study of two modes of anaesthesia.

Ioannidis AS, Papageorgiou K, Alexandraki KI, Massaoutis P, Sinha AJ, Andreou PS.

Int Ophthalmol. 2010 Dec;30(6):703-7. doi: 10.1007/s10792-010-9344-5. Epub 2010 Jan 28.

PMID:
20107867
43.

Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study.

Alexandraki KI, Kaltsas GA, le Roux CW, Fassnacht M, Ajodha S, Christ-Crain M, Akker SA, Drake WM, Edwards R, Allolio B, Grossman AB.

Clin Endocrinol (Oxf). 2010 Mar;72(3):305-11. doi: 10.1111/j.1365-2265.2009.03631.x. Epub 2009 May 16.

PMID:
19473175
44.

The acute effect of Orlistat on dietary glycotoxins in diabetics and healthy women.

Diamanti-Kandarakis E, Piperi C, Alexandraki KI, Papailiou J, Ekonomou F, Koulouri E, Kandarakis H, Creatsas G.

Minerva Endocrinol. 2009 Jun;34(2):97-104.

PMID:
19471234
45.

Corticomedullary mixed adrenal tumor: case report and literature review.

Alexandraki KI, Michail OP, Nonni A, Diamantis D, Giannopoulou I, Kaltsas GA, Tseleni-Balafouta S, Syriou V, Michail PO.

Endocr J. 2009;56(6):817-24. Epub 2009 May 20. Review.

46.

The prevalence and characteristic features of cyclicity and variability in Cushing's disease.

Alexandraki KI, Kaltsas GA, Isidori AM, Akker SA, Drake WM, Chew SL, Monson JP, Besser GM, Grossman AB.

Eur J Endocrinol. 2009 Jun;160(6):1011-8. doi: 10.1530/EJE-09-0046. Epub 2009 Mar 16.

PMID:
19289537
47.

Isolated adrenocorticotropin deficiency and flexion contractures syndrome.

Syriou V, Moisidis A, Tamouridis N, Alexandraki KI, Anapliotou M.

Hormones (Athens). 2008 Oct-Dec;7(4):320-4.

48.

Adrenal incidentalomas: 'the rule of four'.

Alexandraki KI, Grossman AB.

Clin Med (Lond). 2008 Apr;8(2):201-4. No abstract available.

PMID:
18478872
49.

Pituitary-targeted medical therapy of Cushing's disease.

Alexandraki KI, Grossman AB.

Expert Opin Investig Drugs. 2008 May;17(5):669-77. doi: 10.1517/13543784.17.5.669 . Review. Erratum in: Expert Opin Investig Drugs. 2008 Jul;17(7):1141.

PMID:
18447593
50.

Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation.

Alexandraki KI, Piperi C, Ziakas PD, Apostolopoulos NV, Makrilakis K, Syriou V, Diamanti-Kandarakis E, Kaltsas G, Kalofoutis A.

J Clin Immunol. 2008 Jul;28(4):314-21. doi: 10.1007/s10875-007-9164-1. Epub 2008 Jan 26.

PMID:
18224429

Supplemental Content

Loading ...
Support Center